Nova Eye Medical Ltd
ASX:EYE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nova Eye Medical Ltd
ASX:EYE
|
AU |
|
C
|
CLP Holdings Ltd
OTC:CLPHY
|
HK |
|
C
|
Crystal International Group Ltd
HKEX:2232
|
HK |
|
P
|
PF Group Holdings Ltd
HKEX:8221
|
HK |
|
Bajaj Holdings and Investment Ltd
NSE:BAJAJHLDNG
|
IN |
|
C
|
CECO Environmental Corp
NASDAQ:CECO
|
US |
|
S
|
Sunshine Global Circuits Co Ltd
SZSE:300739
|
CN |
|
Steel Partners Holdings LP
NYSE:SPLP
|
US |
|
Norma Group SE
XETRA:NOEJ
|
DE |
|
A
|
Allane SE
XETRA:LNSX
|
DE |
|
V
|
Vatryggingafelag Islands hf
ICEX:VIS
|
IS |
Cash Flow Statement
Cash Flow Statement
Nova Eye Medical Ltd
| Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
(0)
|
(1)
|
(0)
|
(0)
|
(9)
|
(7)
|
1
|
0
|
1
|
2
|
1
|
0
|
0
|
|
| Cash Interest Paid |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Change in Working Capital |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Cash from Operating Activities |
(4)
N/A
|
(1)
+86%
|
5
N/A
|
0
-92%
|
(13)
N/A
|
(11)
+18%
|
(5)
+56%
|
(9)
-81%
|
(7)
+20%
|
(6)
+6%
|
(8)
-23%
|
(7)
+8%
|
(6)
+15%
|
|
| Investing Cash Flow | ||||||||||||||
| Capital Expenditures |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(4)
|
(4)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
(2)
|
(2)
|
89
|
89
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(3)
N/A
|
(3)
+10%
|
88
N/A
|
88
0%
|
(3)
N/A
|
(5)
-53%
|
(5)
+1%
|
(2)
+62%
|
(1)
+59%
|
(0)
+31%
|
(0)
+32%
|
(0)
+52%
|
(0)
-133%
|
|
| Financing Cash Flow | ||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
(42)
|
(42)
|
0
|
0
|
0
|
7
|
0
|
7
|
0
|
6
|
|
| Net Issuance of Debt |
(0)
|
(4)
|
(13)
|
(9)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
(19)
|
(19)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
(0)
N/A
|
(4)
-3 569%
|
(13)
-232%
|
(70)
-430%
|
(62)
+12%
|
(1)
+99%
|
(0)
+36%
|
(1)
-25%
|
7
N/A
|
7
-1%
|
7
+2%
|
7
0%
|
6
-19%
|
|
| Change in Cash | ||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
|
| Net Change in Cash |
(8)
N/A
|
(8)
0%
|
80
N/A
|
18
-77%
|
(78)
N/A
|
(16)
+79%
|
(10)
+39%
|
(11)
-10%
|
(1)
+95%
|
(0)
+96%
|
(1)
-5 413%
|
(0)
+72%
|
(1)
-210%
|
|
| Free Cash Flow | ||||||||||||||
| Free Cash Flow |
(5)
N/A
|
(2)
+71%
|
4
N/A
|
(0)
N/A
|
(14)
-3 354%
|
(14)
-3%
|
(8)
+41%
|
(9)
-10%
|
(7)
+20%
|
(7)
+5%
|
(8)
-18%
|
(8)
+9%
|
(7)
+13%
|
|